Injectors with wearable technology will become more popular with the adoption of remote patient monitoring.
Wilmington, Delaware, United States, Feb. 09, 2024 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The wearable injectors industry was valued at US$ 6.8 billion in 2022. A CAGR of 7.1% is projected from 2023 to 2031, reaching US$ 12.4 billion by 2031. Due to ongoing technology advancements, more advanced and user-friendly wearable injectors will probably be developed. Features including better connection, data analytics, and integration with other digital health platforms will improve the total patient experience. These features will also give medical professionals important insights into patient adherence and treatment efficacy.
The market for wearable injectors is anticipated to be impacted by the move towards personalized medicine, which adjusts treatments based on unique patient characteristics. These gadgets can be customized to provide exact dosages of medication according to each patient’s requirements, enhancing treatment efficacy and reducing adverse effects.
Download sample PDF copy of report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41969
The increased focus on telehealth services and remote patient monitoring will fuel the incorporation of wearable injectors into interconnected healthcare ecosystems. This approach, which enables patients to manage their diseases at home with real-time monitoring by medical personnel, is consistent with the larger movement towards decentralized healthcare delivery.
Regulatory agencies will probably be highly important in setting standards and regulations as wearable injectors become increasingly integrated into healthcare delivery. Adopting these devices in mainstream healthcare can accelerate safety, improve safety, and encourage innovation with the help of health authorities and clear regulatory paths.
Key Findings of Market Report
- The use of subcutaneous injections for drug administration is gaining traction.
- Technology advancements in the design and manufacturing of wearable injectors are driving the market
- North America held the largest share of the wearable injectors market in 2022.
- Based on type, the market for wearable injectors is expected to continue its steady growth.
Global Wearable Injectors Market: Key Players
The wearable injector industry is developing at-home devices that accommodate patients’ needs. The devices are intended to help patients who encounter too many steps in using them mitigate the risk of misuse. Some key wearable injectors market players include:
- BD
- F. Hoffmann-La Roche Ltd.
- Tandem Diabetes Care Inc.
- Insulet Corporation
- Ypsomed AG
- West Pharmaceutical Services Inc.
- CeQur Corporation
- Debiotech S.A.
- Sensile Medical AG (Gerresheimer AG)
- United Therapeutics Corporation
Key Development
- In January 2023, Becton, Dickinson, and Company (BD), a global leader in medical technology, exhibited at Pharmapack 2023, an interna tional industry event dedicated to pharmaceutical packaging.
Global Wearable Injectors Market: Growth Drivers
- Rising incidence of long-term illnesses like diabetes, autoimmune diseases, and heart problems. For long-term therapies, wearable injectors provide a practical and user-friendly option that enhances drug adherence and patient outcomes.
- Wearable injectors are among the efficient and user-friendly medication delivery technologies in high demand as the worldwide burden of chronic diseases continues to rise.
- The market is growing due to technological developments in wearable injector functionality and design. Innovations, including smart connectivity features, dose-tracking capabilities, and user-friendly interfaces, improve the patient experience.
- In addition to increasing patient appeal, these technological advancements give healthcare professionals more confidence to prescribe and suggest wearable injectors, accelerating market growth.
- Wearable injector adoption is being aided by the healthcare industry’s growing emphasis on lowering hospitalization costs and enhancing patient care outside of traditional healthcare settings. By enabling patients to self-administer their drugs, these devices help patients manage their treatment at home and cut down on the number of hospital visits that are necessary.
- This change to home-based care supports freedom and convenience, which drives the market for wearable injectors. It also fits with the larger trend of patient-centric healthcare. All things considered, the convergence of these elements places wearable injectors at the forefront of the rapidly changing drug delivery system scene.
Customization Request for the Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=41969
Global Wearable Injectors Market: Regional Landscape
- Wearable injectors are experiencing robust growth in North America. An increasing number of chronic diseases and ailments requiring long-term pharmaceutical management are prevalent in the region due to the aging population.
- Since wearable injectors provide a convenient and patient-friendly way to administer medication in non-traditional healthcare settings, this demographic shift is a major factor driving their acceptance.
- North American healthcare reimbursement and policy frameworks are significantly influencing the industry. The focus on patient-centered, cost-effective care is pushing medical professionals to look for creative ways to improve treatment outcomes while keeping the overall costs of healthcare as low as possible.
- By allowing patients to self-administer drugs at home, wearable injectors help achieve these objectives by lowering the need for frequent hospital visits and accompanying expenditures.
- The region’s focus on digital health and technological innovation is driving the market growth of wearable injectors. Wearable injectors feature smart features, including mobile applications for remote monitoring and dose tracking, which provide physicians with vital information for optimizing treatment plans. As the healthcare industry expands in North America, so will the technology and willingness to adopt cutting-edge solutions.
Global Wearable Injectors Market: Segmentation
By Type
- On-body Wearable Injectors
- Off-body Wearable Injectors
By Application
- Oncology
- Diabetes
- Autoimmune Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Others
By End User
- Hospitals
- Clinics
- Home Care Settings
- Others
By Region
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East & Africa
Quick Buy- Wearable Injectors Market Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=41969<ype=S
More Trending Reports by Transparency Market Research –
Absorbable Antibacterial Envelope Market– The market was valued at US$ 32.5 Mn in 2021 and it is estimated to grow at a CAGR of 5.8 % from 2022 to 2031 and reach US$ 56.9 Mn by the end of 2031
Dental Gypsum Market– The industry was valued at US$ 117.1 Mn in 2021 and it is estimated to advance at a CAGR of 5.1 % from 2022 to 2031 and reach US$ 180.1 Mn by the end of 2031
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and Encourages Investors to Contact the Firm - June 16, 2025
- Sizzle Acquisition Corp. II Completes $230,000,000 Initial Public Offering - June 16, 2025
- Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - June 16, 2025
